Search Attorneys
   

 

 

 


Publication & News

Subscribe to this RSS feed.

Relying on MSDS Information Not Always Enough for Defendants in "Failure to Warn" Cases

Attorney Advises Additional Steps to Bolster Defense

Memphis – A well-prepared material safety data sheet (MSDS) may not always be sufficient to protect a company facing a “failure to warn” claim, writes Eric Hudson in For The Defense, the journal of the Defense Research Institute.  Hudson advises that chemical manufacturers have all of their employees promote the MSDS in interactions with customers and take steps to ensure that end users are familiar with the information.

Hudson is an attorney with Butler, Snow, O’Mara, Stevens and Cannada, PLLC, (Butler Snow).  DRI, with more than 22,000 members, is the nation’s leading professional organization for corporate counsels and defense attorneys specializing in tort defense.

“Defense counsel can always rely on the MSDS as a part of the defense in a failure to warn claim, but actions taken by the manufacturers before litigation is even contemplated can significantly bolster the defense,” he explains.  The article cites cases in which the MSDS alone failed to provide protection to manufacturers. 

Also cited is York v. Union Carbide Corporation, 586 N.E. 2d 861 (Ind. App. 1992), a case in which the trial court granted a summary judgment for the defense.  Hudson writes that the appellate court noted that the adequacy of warnings is usually an inappropriate matter for summary judgment.  “Nevertheless,” according to Hudson, “the court found that summary judgment was appropriate because of the adequacy of the warning and the means by which it was conveyed.”

Hudson says factors contributing to Union Carbide’s successful outcome included a directive on the MSDS requesting the users of the product notify its employees, agents and contractors of the information in the MSDS and the distribution on more than 100 occasions of a booklet containing detailed safety information.  While noting that the standards in York set a high bar for the defense, he recommends that companies do the following:

  • Where appropriate, provide pamphlets or other written information that reinforce the information contained in the MSDS.
  • Train sales personnel on the information in the MSDS and other warning material.
  • Train sales personnel to identify and watch for misuse of the product while on sales visits.

These actions, while not required, “can significantly improve the defense of common law failure to warn claims,” Hudson writes.  He adds that even if they aren’t sufficient to gain a summary judgment, they will impress a jury and bolster a company’s defense.

Hudson focuses his practice on mass torts, chemical exposure, products liability, and commercial litigation, and is a frequent speaker on those topics.  He is chair of the DRI Young Lawyers Civility and Professionalism Initiative and a member of the DRI Young Lawyers Steering Committee.  He is also active on the Toxic Torts and Environmental Law Committee. 

Print-friendly version


Copyright ButlerSnow Disclaimer





Hudson Featured Presenter at ACI Mass Tort Conference

Butler Snow attorney Eric E. Hudson will co-present "Minimizing the Threat of Medical Monitoring Damages and Plaintiff Recruitment" at the upcoming American Conference Institute's seminar Managing and Resolving Mass Tort Products Liability Claims.  Hudson, a member of Butler Snow's Commercial Litigation Group, has extensive experience as counsel for a number of large corporations in various mass tort cases.

The two-day seminar is scheduled for Wednesday, September 29 through Thursday, September 30, 2010 at the Helmsley Park Lane Hotel in New York, New York.  To register or obtain more information, visit http://www.americanconference.com/MASSTORT/agenda.htm.


Butler Snow to Present The Physician Payment Sunshine Act: A Legal Overview

Machelle D. Shields and Denise D. Burke are featured presenters in the upcoming Q1 Productions conference Medical Device and Diagnostics Corporate Compliance and Ethics Conference.  The program will focus on reimbursement, clinical affairs, legal challenges and corporate compliance and ethics.  Shields and Burke will participate as members of a distinguished panel of experts who will discuss mistakes, setbacks, adjustments and victories while outlining the "next steps" for companies of all sizes.  Shields and Burke, both members of the firm's Pharmaceutical, Medical Device and Healthcare Industry Group will present The Physician Payment Sunshine Act: A Legal Overview.

The conference will be held Thursday, September 30, 2010, in Chicago, Ill.  For registration and additional information, contact Brigitte Durnwald at bdurnwald@q1productions.com. The event brochure is available by clicking here